Eicosapentanoic Acid
Panniculitis
Medical University of ViennaPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Panniculitis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
DHA Medical University of Vienna | Phase 2 | B |
SUNFLOWER OIL Nantes University Hospital | N/A | NR |
Same molecule, other indications
Eicosapentanoic Acid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →